GABRG2 rs11083846: Understanding Your Genetic Variant
The rs11083846 variant is a genetic marker located within the GABRG2 gene, which plays a critical role in brain signaling. This variant is studied for its potential association with the spectrum of genetic epilepsy with febrile seizures plus (GEFS+).
What each genotype means
Common genetic profile
This genotype represents the most frequently observed sequence at this position in the GABRG2 gene. Research into this specific variant is ongoing, and current evidence does not suggest this genotype alone confers a significant risk for epilepsy syndromes. Please consult with a healthcare professional if you have concerns regarding personal or family history of seizures.
This is the most common genotype found across all major global populations.
Common genetic profile
This genotype indicates you carry one copy of the common allele and one copy of the alternative allele. While the GABRG2 gene is known to be associated with various epilepsy syndromes, this specific variant is generally considered a common polymorphism rather than a primary driver of disease. As with any genetic finding, individual health outcomes are influenced by a complex interplay of many genes and environmental factors.
This genotype is observed at varying frequencies across global populations, typically appearing in a significant portion of the general public.
Common genetic profile
This genotype represents the alternative homozygous state for this variant. Current scientific literature does not classify this specific genotype as a pathogenic mutation linked to the spectrum of genetic epilepsy with febrile seizures plus. If you have specific medical concerns or a family history of neurological conditions, it is recommended to discuss these with a qualified clinician or genetic counselor.
This genotype is less common than the CC or CT configurations but is still widely distributed across diverse ancestral groups.
What is the rs11083846 Variant?
The rs11083846 variant is a single nucleotide polymorphism (SNP) located within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated in a region of the genome that influences the expression or function of the gamma-aminobutyric acid (GABA) type A receptor. Because this variant is common in the general population, researchers study it to understand how subtle differences in our genetic code might influence susceptibility to neurological conditions. It is important to note that the presence of a common variant like rs11083846 does not mean an individual will develop a specific condition; rather, it is one of many factors that scientists investigate to understand the complex architecture of human health and disease.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for making the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are essential components of the central nervous system that act as the primary inhibitory neurotransmitter system in the brain. By allowing chloride ions to flow into neurons, these receptors help dampen or 'inhibit' electrical activity, effectively acting as a brake to prevent over-excitation. When the GABRG2 gene functions correctly, it ensures that these receptors are properly assembled and trafficked to the cell surface. Disruptions in this gene can alter the receptor's ability to respond to GABA, potentially leading to an imbalance between excitatory and inhibitory signals in the brain. This delicate balance is crucial for normal neurological function, and its disruption is a known factor in various epilepsy syndromes.
Research and Clinical Associations
Scientific research has linked GABRG2 to a spectrum of epilepsy syndromes, ranging from simple febrile seizures to more complex conditions like genetic epilepsy with febrile seizures plus (GEFS+). While rare, highly disruptive mutations in GABRG2 are well-documented as causes of severe epileptic encephalopathies. The association of common variants like rs11083846 with these conditions is considered moderate and is a subject of ongoing study in the GWAS (Genome-Wide Association Studies) Catalog. It is vital to distinguish between rare, highly penetrant mutations that directly cause disease and common variants that may only slightly modify risk. Current evidence suggests that while GABRG2 is a significant gene in epilepsy research, the clinical impact of any single common variant is often influenced by a combination of other genetic factors and environmental triggers.
Interpreting Your Genetic Information
If you have received information about your rs11083846 genotype, it is important to view it within the context of your overall health. Genetic variants are rarely the sole cause of a medical condition; they are pieces of a much larger puzzle that includes your family history, lifestyle, and environment. You cannot use this information to diagnose yourself or predict future health outcomes with certainty. If you have concerns about epilepsy, seizures, or neurological health, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can help interpret your results in light of your personal medical history. Furthermore, if you are currently taking medication for a neurological condition, never change your dosage or treatment plan based on genetic data without first discussing it with your prescribing physician or pharmacist.
How common is this variant?
The rs11083846 variant is considered a common polymorphism, with its allele frequencies varying across different global ancestral populations as documented in large-scale genomic databases.
Frequently asked questions
Does having the rs11083846 variant mean I have epilepsy?
No. This variant is a common genetic marker and is not a diagnostic test for epilepsy. Most people who carry this variant do not have epilepsy, as the development of such conditions is complex and involves many genetic and environmental factors.
What should I do if I am worried about my GABRG2 results?
If you have concerns about your genetic results or your neurological health, you should schedule an appointment with a doctor or a genetic counselor. They can provide a professional assessment based on your specific medical history and symptoms.
Is GABRG2 related to medication response?
GABRG2 is involved in the function of GABA-A receptors, which are targets for certain medications. However, you should never adjust your medication based on genetic variants without consulting your pharmacist or physician.
Where can I find more information on GABRG2?
You can find reliable information on the GABRG2 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene function and their known associations with human health.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11083846?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.